Find a Cancer Provider

Are you a referring physician?
I am searching for a
Reset Form
Yehoda M. Martei, MD, MSCE

Yehoda M. Martei, MD, MSCE Physician

Instructor A of Medicine

Dr. Martei is employed by Penn Medicine.

Clinical Specialties


  • Hematology
  • Medical Oncology

Programs & Centers:

Board Certification:

  • Internal Medicine, 2014

Clinical Expertise:

  • Breast Cancer

Insurance Accepted

  • Aetna US Healthcare
  • Amerihealth Caritas
  • Amerihealth Caritas Medicare
  • Cigna
  • Cigna HealthSpring
  • Clover Health Plan
  • CVS Health
  • Devon Health Services (Americare)
  • eLAP Services
  • Gateway Health Plan
  • Geisinger Health Plan
  • HealthAmerica / HealthAssurance, a Coventry Plan
  • HealthPartners
  • HealthPartners Medicare
  • HealthSmart
  • Highmark Blue Shield
  • Homestead Smart Health Plans
  • Horizon Blue Cross Blue Shield of New Jersey
  • Humana / Choicecare
  • Independence Blue Cross (Keystone East)
  • Intergroup
  • Keystone First
  • Keystone First Medicare
  • Multiplan
  • NJ Medicaid
  • NJ Qualcare
  • Oxford Health Plan
  • PA Health and Wellness (Centene) Medicare
  • PA Medicaid
  • PA Medicare
  • Preferred Health Care/LGH
  • Provider Partners Health Plan
  • Rail Road Medicare / Palmetto GBA
  • Remedy Partners at Penn Medicine
  • Tricare
  • United Healthcare
  • UnitedHealthcare Community Plan
  • US Family Health Plan
  • Veterans Choice Program

Education and Training

Medical School: Yale University
Residency: UCSF Medical Center and Hospital
Fellowship: Hospital of the University of Pennsylvania


African Organization for Research and Training in Cancer (AORTIC), International American Society of Clinical Oncology (ASCO), National American Society of Clinical Oncology Conquer Cancer Foundation IDEA (International Development and Education Award) Mentorship Program, National Medicine Patient Policy: "Feasibility of expanding the Medicine's Patent Pool's scope to include all patented essential medicines", International World Health organization(WHO: "Shortages of essential cytotoxic medicines for treating children with cancers survey", International

Hospital Affiliation

Dr. Martei is employed by Penn Medicine.

Hospital Privileges:

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.


Selected Publications:

Martei YM, Grover S, Bilker WB, Monare B, Setlhako DI, Ralefala TB, Manshimba P, Gross R, Shulman LN, DeMichele A.: Impact of Essential Medicine Stock Outs on Cancer Therapy Delivery in a Resource-Limited Setting. J Glob Oncol. 5 : 1-11,2019.

Grover S, Martei YM, Puri P, Prabhakar P, Mutebi M, Balogun OD, Price AJ, Freeman AH, Narasmhamurthy M, Rodin D, Rayne S, Zetola N.: Breast cancer and HIV in Sub-Saharan Africa: A complex relationship. J Glob Oncol. (4): 1-11,2018.

Martei YM, Narasimhamurthy M, Prabhakar P, Hutson J, Setlhako DI, Chiyapo S, Ramogola-Masire D, Makozhombwe I, Feldman M, Kayembe MKA, Grover S.: Breast Cancer Pathology Turnaround Time in Botswana J Glob Oncol. (4): 1-7,2018.

Martei YM, Chiyapo S, Grover S, Hanna C, Dryden-Peterson S, Pusoentsi M, Shulman LN, Tapela N.: Methodology to Forecast Volume and Cost of Cancer Drugs in Low- and Middle-Income Countries J Glob Oncol. (4): 1-8,2018.

Martei YM, Chiyapo S, Grover S, Ramogola-Masire D, Dryden-Peterson S, Shulman LN, Tapela N.: Availability of WHO Essential Medicines for Cancer Treatment in Botswana J Glob Oncol. (4): 1-8,2018.

Martei YM, Pace LE, Brock JE, Shulman LN.: Breast Cancer in Low- and Middle-Income Countries: Why We Need Pathology Capability to Solve This Challenge Clin Lab Med. 38 (1): 161-173,2018.

Martei YM, Binagwaho A, Shulman LN.: Affordability of Cancer Drugs in Sub-Saharan Africa: Effects of Pricing on Needless Loss of Life. JAMA Oncol. 3 (10): 1301-1302,2017.

Martei YM, DeMichele A.: Neoadjuvant therapy for breast cancer: State of the science and future directions. Current Breast Cancer Reports 9 (1): 1-12,2017.

Academic Contact Info

3400 Civic Center Blvd.

Philadelphia, PA 19104